Circulating mitochondrial DNA and Toll-like receptor 9 are associated with vascular dysfunction in spontaneously hypertensive rats

Cardiovascular Research

Volumn 107, Issue 1, 2015, Pages 119-130

  McCarthy, Cameron G ^a   Wenceslau, Camilla F ^a   Goulopoulou, Styliani ^b   Ogbi, Safia ^a   Baban, Babak ^c   Sullivan, Jennifer C ^a   Matsumoto, Takayuki ^d   Webb, R Clinton ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b University of North Texas Health Science Center   (United States)

^c AUGUSTA UNIVERSITY   (United States)

^d HOSHI UNIVERSITY   (Japan)

Author keywords

Hypertension; Innate immunity; Mitochondrial DNA; Toll like receptor 9; Vascular dysfunction

Indexed keywords

ACETYLCHOLINE; CPG OLIGODEOXYNUCLEOTIDE; DEOXYRIBONUCLEASE I; DEOXYRIBONUCLEASE II; MITOCHONDRIAL DNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; NORADRENALIN; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 9; CPG-OLIGONUCLEOTIDE; OLIGODEOXYRIBONUCLEOTIDE; TLR9 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; BLOOD PRESSURE REGULATION; BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HYPERTENSION; INNATE IMMUNITY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR SMOOTH MUSCLE; ANIMAL; BLOOD; BLOOD PRESSURE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM; WISTAR KYOTO RAT;

ANIMALS; BLOOD PRESSURE; DNA, MITOCHONDRIAL; ENDOTHELIUM, VASCULAR; FEMALE; HYPERTENSION; IMMUNITY, INNATE; MALE; NITRIC OXIDE; OLIGODEOXYRIBONUCLEOTIDES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TOLL-LIKE RECEPTOR 9;

EID: 84936745270     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvv137     Document Type: Article

References (57)

1. Singh MV, ChapleauMW, Harwani SC, Abboud FM. The immune system and hypertension. Immunol Res 2014;59:243-253.
2. McCarthy CG, Goulopoulou S, Wenceslau CF, Spitler K, Matsumoto T, Webb RC. Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension. Am J Physiol Heart Circ Physiol 2014;306: H184-H196.
3. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12: 991-1045.
4. Matzinger P. The danger model: a renewed sense of self. Science 2002;296:301-305.
5. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008;8:279-289.
6. KryskoDV, Agostinis P, KryskoO, Garg AD, Bachert C, Lambrecht BN, Vandenabeele P. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011;32:157-164.
7. Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF, Lien E, Nilsen NJ, Espevik T, Golenbock DT. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004;5:190-198.
8. Stacey KJ, Young GR, Clark F, Sester DP, Roberts TL, Naik S, Sweet MJ, Hume DA. The molecular basis for the lack of immunostimulatory activity of vertebrate DNA. J Immunol 2003;170:3614-3620.
9. Barton GM, Kagan JC, Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 2006;7: 49-56.
10. Sagan L. On the origin of mitosing cells. J Theor Biol 1967;14:255-274.
11. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, JungerW, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464:104-107.
12. Oka T, Hikoso S, Yamaguchi O, Taneike M, Takeda T, Tamai T, Oyabu J, Murakawa T, Nakayama H, Nishida K, Akira S, Yamamoto A, Komuro I, Otsu K. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 2012;485:251-255.
13. RyterSW, Cloonan SM, Choi AM. Autophagy: a critical regulator of cellular metabolism and homeostasis. Mol Cells 2013;36:7-16.
14. Klinman DM. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 2004;4:249-258.
15. Shintani Y, Drexler HC, Kioka H, Terracciano CM, Coppen SR, Imamura H, Akao M, Nakai J, Wheeler AP, Higo S, Nakayama H, Takashima S, Yashiro K, Suzuki K. Toll-like receptor 9 protects non-immune cells from stress by modulating mitochondrial ATP synthesis through the inhibition of SERCA2. EMBO Rep 2014;15:438-445.
16. Shintani Y, Kapoor A, Kaneko M, Smolenski RT, D'Acquisto F, Coppen SR, Harada-Shoji N, Lee HJ, Thiemermann C, Takashima S, Yashiro K, Suzuki K. TLR9 mediates cellular protection by modulating energy metabolism in cardiomyocytes and neurons. Proc Natl Acad Sci USA 2013;110:5109-5114.
17. OkoshiMP, Matsubara LS, Franco M, CicognaAC, Matsubara BB. Myocyte necrosis is the basis for fibrosis in renovascular hypertensive rats. Braz J Med Biol Res 1997;30: 1135-1144.
18. Gardner DL. Arteriolar necrosis and the prenecrotic phase of experimental hypertension. Q J Exp Physiol Cogn Med Sci 1963;48:156-163.
19. Tan LB, Jalil JE, Pick R, Janicki JS,Weber KT. Cardiac myocyte necrosis induced by angiotensin II. Circ Res 1991;69:1185-1195.
20. Veiko NN, Konorova IL, Neverova ME, Fidelina OV, Mkrtumova NA, Ershova ES, Kon'kova MS, Postnov AI. Delayed appearance of hypertension in spontaneously hypertensive rat (SHR) injected with CpG-rich DNA early in ontogenesis. Biomed Khim 2010; 56:686-699.
21. Bomfim GF, Dos Santos RA, Oliveira MA, Giachini FR, Akamine EH, Tostes RC, Fortes ZB,Webb RC, Carvalho MH. Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats. Clin Sci (Lond) 2012;122:535-543.
22. Tipton AJ, Baban B, Sullivan JC. Female spontaneously hypertensive rats have a compensatory increase in renal regulatory T cells in response to elevations in blood pressure. Hypertension 2014;64:557-564.
23. Baban B, Liu JY, Mozaffari MS. Endoplasmic reticulum stress response and inflammatory cytokines in type 2 diabetic nephropathy: role of indoleamine 2,3-dioxygenase and programmed death-1. Exp Mol Pathol 2013;94:343-351.
24. Nadano D, Yasuda T, Kishi K. Measurement of deoxyribonuclease I activity in human tissues and body fluids by a single radial enzyme-diffusion method. Clin Chem 1993;39: 448-452.
25. Koizumi T.Deoxyribonuclease II (DNase II) activity in mouse tissues and body fluids. Exp Anim 1995;44:169-171.
26. Wenceslau CF, Rossoni LV. Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase/cSRC pathway. J Hypertens 2014;32: 542-554.
27. Mulvany MJ, HalpernW. Mechanical properties of vascular smooth muscle cells in situ. Nature 1976;260:617-619.
28. Rossoni LV, Salaices M, Marin J, Vassallo DV, Alonso MJ. Alterations in phenylephrine-induced contractions and the vascular expression of Na+,K+-ATPase in ouabain-induced hypertension. Br J Pharmacol 2002;135:771-781.
29. Gao L, Mann GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res 2009;82:9-20.
30. d'Uscio LV. eNOS uncoupling in pulmonary hypertension. Cardiovasc Res 2011;92: 359-360.
31. Simao S, Gomes P, Pinto V, Silva E, Amaral JS, Igreja B, Afonso J, Serrao MP, Pinho MJ, Soares-da-Silva P. Age-related changes in renal expression of oxidant and antioxidant enzymes and oxidative stress markers in male SHR and WKY rats. Exp Gerontol 2011; 46:468-474.
32. Ulker S, McMaster D, McKeown PP, Bayraktutan U. Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despite enhanced vascular nitric oxide generation. Cardiovasc Res 2003;59:488-500.
33. Vaziri ND, Ni Z, Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 1998;31:1248-1254.
34. Yeo SJ, Gravis D, Yoon JG, Yi AK. Myeloid differentiation factor 88-dependent transcriptional regulation of cyclooxygenase-2 expression by CpG DNA: role of NF-kappaB and p38. J Biol Chem 2003;278:22563-22573.
35. Wong MS, Vanhoutte PM. COX-mediated endothelium-dependent contractions: from the past to recent discoveries. Acta Pharmacol Sin 2010;31:1095-1102.
36. Bao W, Behm DJ, Nerurkar SS, Ao Z, Bentley R, Mirabile RC, Johns DG, Woods TN, Doe CP, Coatney RW, Ohlstein JF, Douglas SA, Willette RN, Yue TL. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production. J Cardiovasc Pharmacol 2007;49:362-368.
37. Desvarieux M, Demmer RT, Jacobs DR Jr, Rundek T, Boden-Albala B, Sacco RL, Papapanou PN. Periodontal bacteria and hypertension: the oral infections and vascular disease epidemiology study (INVEST). J Hypertens 2010;28:1413-1421.
38. Miyake Y, Yamasaki S. Sensing necrotic cells. Adv Exp Med Biol 2012;738:144-152.
39. Davidovich P, Kearney CJ, Martin SJ. Inflammatory outcomes of apoptosis, necrosis and necroptosis. Biol Chem 2014;395:1163-1171.
40. Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M, Abe Y. Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide. Hypertension 2005;45:438-444.
41. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001;38:581-587.
42. Chitrabamrung S, Rubin RL, Tan EM. Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol Int 1981;1:55-60.
43. Aranow C, Ginzler EM. Epidemiology of cardiovascular disease in systemic lupus erythematosus. Lupus 2000;9:166-169.
44. Rodrigues FL, Silva LE, Hott SC, Bomfim GF, da Silva CA, Fazan R Jr, Resstel LB, Tostes RC, Carneiro FS. Toll-like receptor 9 (TLR9) plays a key role in the autonomic cardiac and baroreflex control of arterial pressure. Am J Physiol Regul Integr Comp Physiol 2015;308:R714-R723.
45. Luscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 1986;8:344-348.
46. Spitler KM, Matsumoto T, Webb RC. Suppression of endoplasmic reticulum stress improves endothelium-dependent contractile responses in aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 2013;305:H344-H353.
47. Alvarez Y, Briones AM, Balfagon G, Alonso MJ, Salaices M. Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses. J Hypertens 2005;23:767-777.
48. Virdis A, Bacca A, Colucci R, Duranti E, Fornai M, Materazzi G, Ippolito C, BernardiniN, Blandizzi C, Bernini G, Taddei S. Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation. Hypertension 2013;62:337-344.
49. Ishida M, Ishida T, Thomas SM, Berk BC. Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ Res 1998;82:7-12.
50. TouyzRM,HeG,WuXH,Park JB, Mabrouk ME, Schiffrin EL. Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients. Hypertension 2001;38:56-64.
51. Chattopadhyay S, Sen GC. Tyrosine phosphorylation in Toll-like receptor signaling. Cytokine Growth Fact Rev 2014;25:533-541.
52. Chockalingam A, RoseWA 2nd, Hasan M, Ju CH, Leifer CA. Cutting edge: a TLR9 cytoplasmic tyrosine motif is selectively required for proinflammatory cytokine production. J Immunol 2012;188:527-530.
53. SanjuanMA, Rao N, LaiKT,GuY, Sun S, Fuchs A, Fung-LeungWP, Colonna M, Karlsson L. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. J Cell Biol 2006;172:1057-1068.
54. Ba D, Takeichi N, Kodama T, Kobayashi H. Restoration of T cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts. J Immunol 1982;128:1211-1216.
55. Guzik TJ, Hoch NE, BrownKA, McCann LA, Rahman A, Dikalov S, Goronzy J,Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007;204:2449-2460.
56. Marvar PJ, Thabet SR, Guzik TJ, Lob HE, McCann LA, Weyand C, Gordon FJ, Harrison DG. Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res 2010; 107:263-270.
57. Singh MV, Abboud FM. Toll-like receptors and hypertension. Am J Physiol Regul Integr Comp Physiol 2014;307:R501-R504.